Leukemia Clinical Trials in Chicago

Showing 801-820 of 821 trials

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

NCT00363974

The purpose of this study is to determine if the drug, called AEG35156, can be safely given to AML patients and whether it effectively reduces levels of a protein (XIAP) to increase the sensitivity of cancer cells to chemotherapy (ara-C and idarubicin) in patients with refractory or relapsed AML.

Leukemia, Myelomonocytic, Acute

Aegera Therapeutics54 participantsStarted Oct 2005

Los Angeles, California, United States • Los Angeles, California, United States • Chicago, Illinois, United States +4 more locations

COMPLETEDPHASE1/PHASE22.2 miles

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

NCT00086099

The primary objectives of this study are: 1. To evaluate whether the addition of amifostine will allow for the safe administration of idarubicin at a dose of 21 mg/m² in combination with standard-dose ara-C in older patients with newly diagnosed, previously untreated acute myeloid leukemia (AML); and 2. To estimate the complete remission rate of induction therapy with amifostine, idarubicin (21 mg/m²), plus ara-C or induction therapy with idarubicin (12 mg/m²) plus ara-C in this patient population.

LeukemiaAcute Myeloid Leukemia

MedImmune LLC54 participantsStarted Jul 2004

San Diego, California, United States • Chicago, Illinois, United States • New Albany, Indiana, United States +16 more locations

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Leukemia Trials in Other Cities

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Amonafide in Combination With Cytarabine in Secondary AML

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

CP-481,715 Nickel Allergy Study.

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Other Conditions in Chicago